Lin Health Raises $11 Million Series A to Fuel Growth of Virtual Chronic Pain Recovery Platform
Oversubscribed round demonstrates strong investor confidence in Lin Health’s neuroscience-based approach to chronic pain DENVER, Dec. 9, 2025…
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival
LAS VEGAS, Dec. 9, 2025 /PRNewswire/ — Avant Technologies, Inc. (OTCQB: AVAI)Â (“Avant” or the “Company”), an emerging biotechnology…
Vincere Cancer Center Begins Recruitment for Clinical Studies of Pioneering Breast Cancer Screen for Women at High Risk
US cancer center partners with Syantra Inc. for further testing of Onco-ID Breast, a whole blood mRNA test…
FDA Issues Formal Guideline Waiving Clinical Efficacy Studies for Biosimilars, Confirming Professor Niazi’s 15-Year Campaign to Cut Biologic Drug Costs
A Landmark Regulatory Shift Validates Professor Sarfaraz K. Niazi’s Vision to Make Biologics as Affordable as Generics CHICAGO,…
The Most Comprehensive Genetic Risk Assessment, Combining Monogenic and Polygenic Insights Across Multiple Diseases
SAN FRANCISCO, Oct. 9, 2025 /PRNewswire/ — Allelica, the global leader in clinical polygenic risk score (PRS) testing,…
Lilly’s Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer’s disease
Approved for earliest symptomatic stages of disease, demonstrating significant slowing of cognitive and functional decline Only therapy with…
Sleep Aids Market to Hit US$ 118.97 Billion by 2033, Growing at 7.8% CAGR
AUSTIN, Texas and TOKYO, Sept. 19, 2025 /PRNewswire/ — According to DataM Intelligence, the global sleep aids market…
In Vitro Diagnostics (IVD) Quality Control Market worth $2.15 billion by 2030 with 5.5% CAGR
DELRAY BEACH, Fla., Sept. 19, 2025 /PRNewswire/ — The global In Vitro Diagnostics Quality Control Market, valued at…